Method for massively preparing midkine antisense oligodeoxynucleotide nano-liposomes for injection
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUZHOU CENT HOSPITAL
- Publication Date
- 2013-03-27
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] technical field
[0002] The invention belongs to the technical field of preparation of anti-liver cancer drugs, and relates to a method for large-scale preparation of midkine antisense oligonucleotide nano-liposomes.
[0003] Background technique
[0004] Primary hepatocellular carcinoma (hepatocellular carcinoma, HCC) is a highly invasive, highly metastatic solid malignant tumor, but there is still a lack of ideal treatment.
[0005] Midkine (MK) is a newly discovered pro-angiogenic factor. Basic heparin-binding protein expressed only in mid-embryonic and adult kidneys. Existing studies have shown that MK mRNA and protein are highly expressed in many human tumor tissues such as liver cancer, while various normal tissues have only low or no expression, and are related to the occurrence, invasion and metastasis, angiogenesis and prognosis of liver cancer. are closely related, and angiogenesis is the basis for unrestricted invasion, growth and metastasis of liver ca...